Instrument Inactif

Communiqués SYNTH MR Swiss Exchange

Actions

SE0005454865

Equipement et technologie médicale avancés

Cours en clôture Swiss Exchange
- ^SEK	-

12/05	Synthetic MR : repli du chiffre d'affaires mais réduction de la perte d'exploitation	FW
12/05	SyntheticMR AB (publ) publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

27/05	Report from Annual General Meeting in SyntheticMR AB (publ)	AQ
21/04	Notice to attend the Annual General Meeting of SyntheticMR AB (publ)	AQ
09/04	SyntheticMR publishes Annual Report for 2025	AQ
07/04	SyntheticMR : Change of date for the Annual General Meeting in SyntheticMR AB (publ)	PU
07/04	SyntheticMR: Change of date for the Annual General Meeting in SyntheticMR AB (publ)	PU
11/02	SyntheticMR : rights issue has been registered – conversion of BTA into shares	PU
11/02	SyntheticMR: SyntheticMR’s rights issue has been registered – conversion of BTA into shares	PU
11/02	SyntheticMR's rights issue has been registered - conversion of BTA into shares	AQ
06/02	Year-End report January - December 2025	AQ
04/02	SyntheticMR: SyntheticMR publishes the outcome of the rights issue	PU
04/02	SyntheticMR publishes the outcome of the rights issue	AQ
20/01	SyntheticMR : Today the subscription period commences in SyntheticMR AB’s rights issue	PU
20/01	SyntheticMR: Today the subscription period commences in SyntheticMR AB’s rights issue	PU
20/01	Today the subscription period commences in SyntheticMR AB's rights issue	AQ
19/01	SyntheticMR: SyntheticMR AB publishes information document regarding the rights issue	PU
19/01	SyntheticMR AB publishes information document regarding the rights issue	AQ
19/01	SyntheticMR AB publishes financial guidance ahead of the forthcoming rights issue	AQ
16/01	SyntheticMR : Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering	PU
16/01	SyntheticMR: Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR’s Position with a Broader Neuroimaging Offering	PU
16/01	Regulatory Approval for ARIA Monitoring Strengthens SyntheticMR's Position with a Broader Neuroimaging Offering	AQ
15/01	SyntheticMR: SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue	PU
15/01	SyntheticMR AB announces intention to publish financial guidance ahead of upcoming rights issue	AQ
09/01	SyntheticMR: Report from the extraordinary general meeting in SyntheticMR AB (publ)	PU
09/01	Report from the extraordinary general meeting in SyntheticMR AB (publ)	AQ
18/12	SyntheticMR: SyntheticMR AB resolves on a fully secured rights issue of approximately SEK 32.8 million	PU